95313-04-5 Usage
Uses
Used in Pharmaceutical Industry:
1-((3-hydroxy)-4-(hydroxymethyl)cyclopentyl)-4-amino-5-(2-bromovinyl)-2(1H)-pyrimidinone is used as a potential therapeutic agent for various diseases due to its pyrimidine nucleoside structure and the presence of functional groups that may contribute to its biological activity.
Used in Antiviral Applications:
In the field of antiviral research, 1-((3-hydroxy)-4-(hydroxymethyl)cyclopentyl)-4-amino-5-(2-bromovinyl)-2(1H)-pyrimidinone may be utilized as an antiviral agent, leveraging its pyrimidine nucleoside properties to interfere with viral replication and infection processes.
Used in Antitumor Applications:
1-((3-hydroxy)-4-(hydroxymethyl)cyclopentyl)-4-amino-5-(2-bromovinyl)-2(1H)-pyrimidinone may also be employed as an antitumor agent, where its unique structure could potentially target cancer cells and inhibit their growth, making it a candidate for further investigation in oncology.
Used in Antiparasitic Applications:
Given the known activities of pyrimidine nucleosides against parasites, 1-((3-hydroxy)-4-(hydroxymethyl)cyclopentyl)-4-amino-5-(2-bromovinyl)-2(1H)-pyrimidinone could be explored for its potential as an antiparasitic agent, helping to combat various parasitic infections.
Check Digit Verification of cas no
The CAS Registry Mumber 95313-04-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,5,3,1 and 3 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 95313-04:
(7*9)+(6*5)+(5*3)+(4*1)+(3*3)+(2*0)+(1*4)=125
125 % 10 = 5
So 95313-04-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H16BrN3O3/c13-2-1-7-5-16(12(19)15-11(7)14)9-3-8(6-17)10(18)4-9/h1-2,5,8-10,17-18H,3-4,6H2,(H2,14,15,19)/b2-1+/t8-,9?,10+/m0/s1
95313-04-5Relevant academic research and scientific papers
Synthesis and Antiviral Activity of the Carbocyclic Analogues of (E)-5-(2-Halovinyl)-2'-deoxyuridines and (E)-5-(2-Halovinyl)-2'-deoxycytidines
Herdewijn, Piet,Clercq, Erik De,Balzarini, Jan,Vanderhaeghe, Hubert
, p. 550 - 555 (2007/10/02)
The carbocyclic analogues of the potent and selective antiherpes agents (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU), (E)-5-(2-iodovinyl)-2'-deoxyuridine (IVDU), and (E)-5-(2-bromovinyl)-2'-deoxycytidine (BVDC) were synthesized by conventional methods with use of carbocyclic 2'-deoxyuridine as starting material.C-BVDU, C-IVDU, and C-BVDC were equally selective, albeit slightly less potent, in their antiherpes action than BVDU, IVDU, and BVDC.Although resistant to degradation by pyrimidine nucleoside phosphorylases, C-BVDU did not prove more effective than BVDU in the systemic (oral, intraperitoneal) or topical treatment of HSV-1 infections in mice.
